ES2073165T3 - Metodos y composiciones para el tratamiento de enfermedades malignas a las que esta asociada una proteina quinasa. - Google Patents

Metodos y composiciones para el tratamiento de enfermedades malignas a las que esta asociada una proteina quinasa.

Info

Publication number
ES2073165T3
ES2073165T3 ES91906924T ES91906924T ES2073165T3 ES 2073165 T3 ES2073165 T3 ES 2073165T3 ES 91906924 T ES91906924 T ES 91906924T ES 91906924 T ES91906924 T ES 91906924T ES 2073165 T3 ES2073165 T3 ES 2073165T3
Authority
ES
Spain
Prior art keywords
compositions
treatment
methods
protein kinase
malignant diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906924T
Other languages
English (en)
Inventor
Edmond H Fischer
Edwin G Krebs
Nicholas K Tonks
Deborah E Cool
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington Research Foundation
Original Assignee
Washington Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington Research Foundation filed Critical Washington Research Foundation
Application granted granted Critical
Publication of ES2073165T3 publication Critical patent/ES2073165T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTAN METODOS Y COMPUESTOS PARA EL TRATAMIENTO DE ENFERMEDADES EN LAS CUALES ESTE ASOCIADA UNA QUINASA DE TIROSINA. LAS ENFERMEDADES PUEDEN TRATARSE CON UN VEHICULO DE TRANFERENCIA DE GEN CAPAZ DE INFECTAR LAS CELULAS MALIGNAS, EN EL QUE EL VEHICULO DE TRANSFERENCIA DEL GEN SOPORTA UNA CONSTRUCCION DE DNA QUE COMPRENDE UNA SECUENCIA DE DNA QUE CODIFICA UNA FOSFATASA DE TIROSINA DE LA PROTEINA (PTPASA). SECUENCIAS DE DNA ADECUADAS INCLUYEN AQUELLAS QUE CODIFICAN LAS PTPASAS DE TIPO SALVAJE, O TRUNCADAS EN EL TERMINO CARBOXIL.
ES91906924T 1990-03-14 1991-03-14 Metodos y composiciones para el tratamiento de enfermedades malignas a las que esta asociada una proteina quinasa. Expired - Lifetime ES2073165T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49403690A 1990-03-14 1990-03-14

Publications (1)

Publication Number Publication Date
ES2073165T3 true ES2073165T3 (es) 1995-08-01

Family

ID=23962758

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906924T Expired - Lifetime ES2073165T3 (es) 1990-03-14 1991-03-14 Metodos y composiciones para el tratamiento de enfermedades malignas a las que esta asociada una proteina quinasa.

Country Status (9)

Country Link
EP (2) EP0627489B1 (es)
JP (1) JPH05505527A (es)
AT (2) ATE170561T1 (es)
CA (1) CA2078010A1 (es)
DE (2) DE69130117D1 (es)
DK (1) DK0520029T3 (es)
ES (1) ES2073165T3 (es)
GR (1) GR3017164T3 (es)
WO (1) WO1991013989A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE911115A1 (en) * 1990-04-10 1991-10-23 Canji Inc Gene therapy for cell proliferative diseases
US5536636A (en) * 1991-06-26 1996-07-16 Beth Israel Hospital Methods for identifying a tyrosine phosphatase abnormality associated with neoplastic disease
GB9214754D0 (en) * 1992-07-10 1992-08-19 Univ Singapore Tumour treatment
MX9304769A (es) * 1992-08-05 1994-05-31 Max Planck Gesellschaft Subfamilia ptp-d de fosfatasas de la proteina tirosina.
WO1997006262A1 (en) * 1995-08-10 1997-02-20 Incyte Pharmaceuticals, Inc. Non-receptor type human protein tyrosine phosphatase
WO1997035019A1 (en) * 1996-03-22 1997-09-25 Genentech, Inc. Protein tyrosine phosphatases of hematopoietic cells
US6238902B1 (en) 1996-03-22 2001-05-29 Genentech, Inc. Protein tyrosine phosphatases
US6248327B1 (en) 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US7176289B1 (en) 1998-09-11 2007-02-13 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US6485974B1 (en) 2001-05-18 2002-11-26 Isis Pharmaceuticals, Inc. Antisense modulation of PTPN2 expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase

Also Published As

Publication number Publication date
DE69110034T2 (de) 1995-10-05
EP0627489A1 (en) 1994-12-07
DE69130117D1 (de) 1998-10-08
WO1991013989A1 (en) 1991-09-19
EP0520029A1 (en) 1992-12-30
DK0520029T3 (da) 1995-10-16
GR3017164T3 (en) 1995-11-30
ATE170561T1 (de) 1998-09-15
EP0627489B1 (en) 1998-09-02
JPH05505527A (ja) 1993-08-19
EP0520029B1 (en) 1995-05-24
DE69110034D1 (de) 1995-06-29
CA2078010A1 (en) 1992-09-15
ATE123064T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
Kishi et al. Human serum deoxyribonuclease I (DNase I) polymorphism: pattern similarities among isozymes from serum, urine, kidney, liver, and pancreas.
FI922812A (fi) Stabil oeverfoering av dna till bakteriernas arvanslag.
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DK1218509T3 (da) Fibroblast vækstfaktorlignende polypeptider
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DK478786A (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
ES2073165T3 (es) Metodos y composiciones para el tratamiento de enfermedades malignas a las que esta asociada una proteina quinasa.
DK494681A (da) Femgangsmaade til fremstilling af interferoner
ATE310819T1 (de) Säugetieren apoptosis inhibitorprotein genfamilie,primers, probes und verfahren zur nachweis
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
FI831818L (fi) Mikrobiologiskt framstaellda - och -interferoner, dessa interferoner kodande dna-sekvenser, dennagenetiska information innehaollande mikroorganismer och deras framstaellningsfoerfarande
DE3587875T3 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
Kim et al. Purification and partial characterization of (6‐4) photoproduct DNA photolyase from Xenopus laevis
SE8801701D0 (sv) Production technology based on enzymic method
DE3688324D1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
BR9815602A (pt) Composição e processo para induzir uma respostaem células sensìveis de um animal para tratar umcancer
BR9712793A (pt) Fatores homólogos (fhfs) ao fator do desenvolvimento de fibroblasto e métodos de uso
SE7806087L (sv) Forfarande for rening av nukleotidsekvenser lempliga som syntetiseringsmall i bakterier, mikroorganism innefattande dylik nukleotidsekvens samt rekombinant dna-overforingsvektor innefattande dylik nukleotid
DE3782560T2 (de) Hefestaemme zur expression fremder gene.
DE69721484D1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
Geithe et al. Isolation of a homogeneous morphogenetic factor, inducing mesoderm and endoderm derived tissues in Triturus ectoderm
FI950516A (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
ATE403716T1 (de) Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen
PT778347E (pt) Proteina ligante a atp e acidos nucleicos com propriedade de helicase e de atpase
CA2347371A1 (en) HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 520029

Country of ref document: ES